Abstract:Background
Bacterial vaginosis (BV) is a common imbalance of the vaginal microbiota characterized by overgrowth of diverse Actinobacteria, Firmicutes, and Gram-negative anaerobes. Women with BV are at increased risk of secondary reproductive tract infections and adverse pregnancy outcomes. However, which specific bacteria cause clinical features of BV is unclear.
Methods
We previously demonstrated that Gardnerella vaginalis c… Show more
“…In this model, G. vaginalis titers in the vagina and uterine horns were not significantly different between mono and co-infected groups. Consistent with the G. vaginalis inoculation model reported in 2013, no clinical signs of inflammation were observed in the vaginas or uterine horns of mono or co-infected animals (Gilbert et al, 2013(Gilbert et al, , 2019.…”
Section: G Vaginalis Encourages Ascending Uterine Infection By Prevosupporting
confidence: 87%
“…In addition to findings that certain strains of Gardnerella can reproduce features of BV in experimental models, there is also evidence to support the conclusion that Gardnerella can influence whether other organisms cause pathophysiology. Specifically, vaginal colonization by the JCP8151B strain caused mice to experience higher titer ascending uterine infections by Prevotella bivia compared to animals that received only P. bivia (Gilbert et al, 2019). The JCP8151B strain was also able to trigger recurrent UTI caused by uropathogenic E. coli that re-emerged from long lasting reservoirs inside epithelial cells in response to bladder exposure to Gardnerella, but not Lactobacillus crispatus (Gilbert et al, 2017).…”
Section: Can Gardnerella Reproduce Features Of Bv In Experimental Modmentioning
confidence: 97%
“…In 2019, Gilbert et al described an estradiol-treated mouse coinfection model with G. vaginalis and Prevotella bivia (Gilbert et al, 2019). Prevotella species are prevalent in the vaginal microbiome of women with BV (Srinivasan et al, 2012).…”
Section: G Vaginalis Encourages Ascending Uterine Infection By Prevomentioning
confidence: 99%
“…Differences in the mouse strain, housing conditions, and/or vaginal microbiome could strongly impact susceptibility and response to G. vaginalis infection. For example, Teixeira et al (2012) observed "inflammatory lesions" upon G. vaginalis infection in their germ-free mice, while Gilbert et al (2013Gilbert et al ( , 2019 have specifically noted a lack of inflammatory response in their model using C57Bl/6 mice raised under conventional conditions (Teixeira et al, 2012;Gilbert et al, 2013Gilbert et al, , 2019. Additionally, many of the mouse models require β-estradiol administration to bring mice into pro-estrus for the duration of the experiment and avoid the PMN-rich post-ovulation period of the estrus cycle (Gilbert et al, 2013).…”
Koch's postulates dictate the use of experimental models to illustrate features of human disease and provide evidence for a singular organism as the cause. The underlying cause(s) of bacterial vaginosis (BV) has been debated in the literature for over half a century. In 1955, it was first reported that a bacterium now known as Gardnerella vaginalis may be the cause of a condition (BV) resulting in higher vaginal pH, thin discharge, a fishy odor, and the presence of epithelial cells covered in bacteria. Here we review contemporary and historical studies on BV with a focus on reports of experimental infections in human or animal models using Gardnerella vaginalis. We evaluate experimental evidence for the hypothesis that G. vaginalis is sufficient to trigger clinical features of BV or relevant health complications associated with the condition. Additionally, we evaluate in vivo models of co-infection employing G. vaginalis together with other bacterial species to investigate evidence for the hypothesis that G. vaginalis may encourage colonization or virulence of other potential pathogens. Together, these studies paint a complex picture in which G. vaginalis has both direct and indirect roles in the features, health complications, and co-infections associated with BV. We briefly review the current taxonomic landscape and genetic diversity pertinent to Gardnerella and note the limitations of sequence-based studies using different marker genes and priming sites. Although much more study is needed to refine our understanding of how BV develops and persists within the human host, applications of the experimental aspects of Koch's postulates have provided an important glimpse into some of the causal relationships that may govern this condition in vivo.
“…In this model, G. vaginalis titers in the vagina and uterine horns were not significantly different between mono and co-infected groups. Consistent with the G. vaginalis inoculation model reported in 2013, no clinical signs of inflammation were observed in the vaginas or uterine horns of mono or co-infected animals (Gilbert et al, 2013(Gilbert et al, , 2019.…”
Section: G Vaginalis Encourages Ascending Uterine Infection By Prevosupporting
confidence: 87%
“…In addition to findings that certain strains of Gardnerella can reproduce features of BV in experimental models, there is also evidence to support the conclusion that Gardnerella can influence whether other organisms cause pathophysiology. Specifically, vaginal colonization by the JCP8151B strain caused mice to experience higher titer ascending uterine infections by Prevotella bivia compared to animals that received only P. bivia (Gilbert et al, 2019). The JCP8151B strain was also able to trigger recurrent UTI caused by uropathogenic E. coli that re-emerged from long lasting reservoirs inside epithelial cells in response to bladder exposure to Gardnerella, but not Lactobacillus crispatus (Gilbert et al, 2017).…”
Section: Can Gardnerella Reproduce Features Of Bv In Experimental Modmentioning
confidence: 97%
“…In 2019, Gilbert et al described an estradiol-treated mouse coinfection model with G. vaginalis and Prevotella bivia (Gilbert et al, 2019). Prevotella species are prevalent in the vaginal microbiome of women with BV (Srinivasan et al, 2012).…”
Section: G Vaginalis Encourages Ascending Uterine Infection By Prevomentioning
confidence: 99%
“…Differences in the mouse strain, housing conditions, and/or vaginal microbiome could strongly impact susceptibility and response to G. vaginalis infection. For example, Teixeira et al (2012) observed "inflammatory lesions" upon G. vaginalis infection in their germ-free mice, while Gilbert et al (2013Gilbert et al ( , 2019 have specifically noted a lack of inflammatory response in their model using C57Bl/6 mice raised under conventional conditions (Teixeira et al, 2012;Gilbert et al, 2013Gilbert et al, , 2019. Additionally, many of the mouse models require β-estradiol administration to bring mice into pro-estrus for the duration of the experiment and avoid the PMN-rich post-ovulation period of the estrus cycle (Gilbert et al, 2013).…”
Koch's postulates dictate the use of experimental models to illustrate features of human disease and provide evidence for a singular organism as the cause. The underlying cause(s) of bacterial vaginosis (BV) has been debated in the literature for over half a century. In 1955, it was first reported that a bacterium now known as Gardnerella vaginalis may be the cause of a condition (BV) resulting in higher vaginal pH, thin discharge, a fishy odor, and the presence of epithelial cells covered in bacteria. Here we review contemporary and historical studies on BV with a focus on reports of experimental infections in human or animal models using Gardnerella vaginalis. We evaluate experimental evidence for the hypothesis that G. vaginalis is sufficient to trigger clinical features of BV or relevant health complications associated with the condition. Additionally, we evaluate in vivo models of co-infection employing G. vaginalis together with other bacterial species to investigate evidence for the hypothesis that G. vaginalis may encourage colonization or virulence of other potential pathogens. Together, these studies paint a complex picture in which G. vaginalis has both direct and indirect roles in the features, health complications, and co-infections associated with BV. We briefly review the current taxonomic landscape and genetic diversity pertinent to Gardnerella and note the limitations of sequence-based studies using different marker genes and priming sites. Although much more study is needed to refine our understanding of how BV develops and persists within the human host, applications of the experimental aspects of Koch's postulates have provided an important glimpse into some of the causal relationships that may govern this condition in vivo.
“…However, Lactobacillus -dominated vaginal microbiota is displaced by the overgrowth of Gardnerella species and other BVAB when vaginal dysbiosis happens [ 100 ]. Recent studies have demonstrated that the synergistic interactions between BVAB such as G. vaginalis and A. vaginae significantly enhanced the severity of BV by increasing bacterial burden [ 101 , 102 ]. Another important feature of BV is polymicrobial biofilm formation mainly by G. vaginalis , while the presence of other co-colonised BVAB was shown to enhance the biofilm thickness of G. vaginalis growth [ 85 , 103 – 105 ].…”
Section: Indigenous Vaginal Microbiota In Womenmentioning
Human vagina is colonised by a diverse array of microorganisms that make up the normal microbiota and mycobiota. Lactobacillus is the most frequently isolated microorganism from the healthy human vagina, this includes Lactobacillus crispatus, Lactobacillus gasseri, Lactobacillus iners, and Lactobacillus jensenii. These vaginal lactobacilli have been touted to prevent invasion of pathogens by keeping their population in check. However, the disruption of vaginal ecosystem contributes to the overgrowth of pathogens which causes complicated vaginal infections such as bacterial vaginosis (BV), sexually transmitted infections (STIs), and vulvovaginal candidiasis (VVC). Predisposing factors such as menses, pregnancy, sexual practice, uncontrolled usage of antibiotics, and vaginal douching can alter the microbial community. Therefore, the composition of vaginal microbiota serves an important role in determining vagina health. Owing to their Generally Recognised as Safe (GRAS) status, lactobacilli have been widely utilised as one of the alternatives besides conventional antimicrobial treatment against vaginal pathogens for the prevention of chronic vaginitis and the restoration of vaginal ecosystem. In addition, the effectiveness of Lactobacillus as prophylaxis has also been well-founded in long-term administration. This review aimed to highlight the beneficial effects of lactobacilli derivatives (i.e. surface-active molecules) with anti-biofilm, antioxidant, pathogen-inhibition, and immunomodulation activities in developing remedies for vaginal infections. We also discuss the current challenges in the implementation of the use of lactobacilli derivatives in promotion of human health. In the current review, we intend to provide insights for the development of lactobacilli derivatives as a complementary or alternative medicine to conventional probiotic therapy in vaginal health.
ObjectiveTo identify the vaginal microbial signature in women with chronic endometritis (CE) and investigate the potential of vaginal microbiome characterization as a novel diagnostic tools for CE.MethodsA cross‐sectional study was conducted to compare the characteristics of the vaginal microbiome in 98 women who underwent endometrial biopsy for routine clinical inspection of infertility (49 women diagnosed with CE and 49 with non‐CE). The vaginal microbiome was analyzed using 16S ribosomal RNA gene amplicon sequencing. The study included an analysis of diversity, bacterial abundance, and microbial function. In addition, microbial markers were identified, and a CE classifier was developed.ResultsThe relative abundances of genera, including Bifidobacterium, Prevotella and Gardnerella, were found to be different between the two groups. Analysis of the Kyoto Encyclopedia of Genes and Genomes pathways reported differential expression in metabolism‐related pathways in the two groups. We identified four microbial markers of CE (Enterobacter, Prevotella, Faecalibacterium, and Phascolarctobacterium) and developed a predictive classifier for diagnosing CE, achieving an area under the curve of 83.26%.ConclusionThe results of the current study revealed that, compared with the non‐CE controls, patients with CE have a different vaginal microbiota, highlighting the diagnostic significance of the vaginal microbiome as a promising noninvasive biomarker in detecting CE.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.